Decentralization of Clinical Trials: Taking Into Account All Stakeholder Perspectives

There is no question that decentralizing clinical trials will change many things for patients, sites, and sponsors. There are certainly challenges to overcome, but there are as many, if not more, opportunities that technology can enable.

ERTについて

ERT (eResearch Technology) is a global data and technology company that minimizes uncertainty and risk in clinical trials so that its customers can move ahead with confidence. ERTは50年近い臨床経験および治療経験を有しており、実際に機能することの知識と今後の出来事の予測を調和させて、基準を低下させることなく適応することができます。

Powered by the company’s EXPERT® technology platform, ERT’s solutions enhance trial oversight, enable site optimization, increase patient engagement and measure the efficacy of new clinical treatments while ensuring patient safety. In 2019, 75% of all FDA drug approvals came from ERT-supported studies. Pharma companies, biotechs, and CROs have relied on ERT solutions across 16,000 studies, spanning more than five million patients to date. ERTは、臨床試験のリスクが問題になる前にこのリスクを明確にして、顧客が臨床治療を迅速に患者に適用することを可能にします。しかも自信をもって。

For more information, please visit ert.com or follow us on LinkedIn and Twitter.

ERT Media Contact
Terry Stanulis
Director, Thought Leadership and Public Relations
terry.stanulis@ert.com
+1 862-288-0329

シェアする